Tuesday, 29 September 2020

CureVac Plans Global Late-stage COVID-19 Vaccine Trial In Fourth Quarter

Germany's CureVac NV said on Tuesday it has started a midstage study testing its experimental coronavirus vaccine and plans to begin a decisive global trial with about 30,000 volunteers in the fourth quarter.

from Top Business News- News18.com https://ift.tt/36hX4sl
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Beyond Borders: The True Origins Of India's Favorite Brands - Colgate, Bata And Maruti

Bata grew into one of the world's leading shoemakers, with an impressive annual sale of 150 million pairs of shoes across more than 70 c...